The National Agency for Food and Drug Administration and Control (NAFDAC) has issued a stern warning to healthcare providers and the general public regarding the World Health Organization’s (WHO) medical product alert on five contaminated syrup and suspension medicines.
Originally discovered in the Maldives and Pakistan, the affected products include ALERGO Syrup, EMIDONE Suspension, MUCORID Syrup, ULCOFIN Suspension, and ZINCELL Syrup, all manufactured by PHARMIX LABORATORIES (PVT.) LTD in Pakistan.
A total of 23 batches of these substandard products have been identified, posing a severe risk to health, particularly in children.
NAFDAC urged importers, distributors, retailers, and consumers to exercise extreme caution and heightened vigilance within the supply chain to prevent the importation, distribution, sale, and use of these hazardous cough syrups.
The agency emphasizes the importance of obtaining medical products only from authorized and licensed suppliers, with a meticulous check on authenticity and physical condition.
“National Agency for Food and Drug Administration and Control (NAFDAC) is notifying healthcare providers and the public of the WHO medical product alert on five (5) contaminated syrup and suspension medicines initially detected in the Maldives and Pakistan.
The five products are ALERGO Syrup, EMIDONE Suspension, MUCORID Syrup, ULCOFIN Suspension, and ZINCELL Syrup.
A total of 23 batches of these products are affected. The stated manufacturer of all the affected products is PHARMIX LABORATORIES (PVT.) LTD (Pakistan).
These substandard products referenced in this alert are unsafe and their use, especially in children, may result in serious injury or death. Although these products are not registered by NAFDAC, they may have been distributed, through formal and informal markets, to other countries or regions including Nigeria.
NAFDAC implores importers, distributors, retailers and consumers to exercise caution and increase vigilance within the supply chain to avoid the importation, distribution, sale and use of the substandard cough syrups. All medical products must be obtained from authorized/licensed suppliers. The products’ authenticity and physical condition should be carefully checked.” NAFDAC wrote.
